(METRIC trial)
Date: Thursday 22nd January 2026
Time: 2.30pm – 3.30pm
Delivered: MS Teams (joining details will be sent upon sign up)
Equally Well UK invites you to an online event in collaboration with Pennine Care Trust.
A new trial (METRIC trial) is investigating the clinical and cost effectiveness of adding metformin to usual care, versus placebo with usual care, in preventing weight gain caused by antipsychotic treatment in people with a first episode of psychosis.
This study is examining whether metformin can help stop or lessen weight gain in people taking antipsychotics during their first episode of psychosis. It includes 340 participants who started antipsychotic medication within the last month and is taking place in 15–25 mental health services across the UK.
We will be joined by the trials investigators Dr Paul French, Professor Richard Holt and Katherine Paterson who will provide an overview of the study.
By attending this webinar, our members will gain first-hand insights from leading researchers into how the latest evidence-base will aim to reduce cardiovascular risk and manage weight for people with severe mental illness.
Please sign up to attend below.
Please note this webinar is open to members only, but please do share this invite with your colleagues. If you have any questions, please get in touch with shizana.arshad@centreformentalhealth.org.uk
Please note that the webinar will be recorded and shared on our website and on social media. You can find out more about how we protect the data you use to sign up by reading ourprivacy policy.
